Immunitybio Inc. share price logo

Immunitybio Inc. Share Price

NASDAQ: IBRX

Mid Cap

$2.76

-0.05

(-1.78%)

as on

Immunitybio Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.74
    $2.94
    downward going graph

    0.72%

    Downside

    6.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.83
    $7.48
    downward going graph

    33.70%

    Downside

    171.01%

    Upside

    downward going graph

Immunitybio Inc. share price movements today

Previous Close
$2.81
Open
$2.83
Volume
10.3M
Day's Low - High
$2.74 - $2.94
52 Week Low - High
$1.83 - $7.48

Immunitybio Inc. Historical Returns

1 Month Return
+ 10.2 %
3 Month Return
-1.06 %
1 Year Return
-15.36 %
3 Year Return
-53.63 %
5 Year Return
0 %

Immunitybio Inc. Stock Fundamentals & Key Indicators

Check Immunitybio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6B

EPS (TTM)

-0.4433

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.43

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-269.1M

Revenue (TTM)

56.6M

Profit Margin

0.00%

Return On Equity TTM

425479700.00%

Immunitybio Inc. Stock Valuation

Track how Immunitybio Inc. P/E has moved over time to understand its valuation trends.

Immunitybio Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Today (-4.43x)

September 17, 2025

Industry (10.13x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.43x

Immunitybio Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunitybio Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.6BNA-4.430.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Immunitybio Inc. Stock including INR - Dollar returns

The Immunitybio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immunitybio Inc. investment value today

Current value as on today

₹87,731

Returns

₹12,269

(-12.27%)

Returns from Immunitybio Inc. Stock

₹16,867 (-16.87%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Immunitybio Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Immunitybio Inc.. Average target price of $10.2

Immunitybio Inc. Share Price Target

Get share price movements and forecasts by analysts on Immunitybio Inc..

What analysts predicted

72.94%UPSIDE

Target Price

$10.2

Current Price

$2.76

Analyzed by

8 Analysts

Target

$10.20

Immunitybio Inc. target price $10.2, a slight upside of 72.94% compared to current price of $2.76. According to 8 analysts rating.

Immunitybio Inc. Stock's Interest Amongst Investors

Investment in Immunitybio Inc. Shares on INDmoney has dropped by -11.25% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-11.25% versus previous 30 day period

Search interest for Immunitybio Inc. Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

Immunitybio Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
1
6
7
16
26
Gross Profit
-5
-6
-4
-4
-4
1
6
7
16
26
Operating Income
-111
-85
-80
-84
-95
-99
-80
-69
-64
-71
EBITDA
-80
-99
-56
-196
-92
-91
-41
-17
-64
-59
Interest Expense
29
32
35
32
37
39
40
37
28
28
Depreciation
4
4
4
4
4
4
4
4
3
3
Income Before Tax
-116
-138
-95
-233
-134
-134
-85
-59
-129
-92
Income Tax Expense
34
20
-4
0
0
-4
-
0
-
0
Net Income
-151
-137
-95
-233
-134
-134
-85
-59
-129
-92
Net Profit Margin
-41989.44%
-336290.24%
-116563.41%
-167907.91%
-335272.50%
-12852.34%
-1404.01%
-783.40%
-784.92%
-350.26%

Immunitybio Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
0
0
2
0
0
0
0
14
Gross Profit
0
0
0
3
-6
-8
0
-23
0
14
Operating Income
-238
-124
-99
-98
-156
-220
-330
-351
-362
-344
EBITDA
-235
-117
-90
-86
-142
-187
-315
-335
-436
-241
Interest Expense
-
0
0
0
5
9
14
63
129
154
Depreciation
-
-
-
-
14
12
14
18
19
17
Income Before Tax
-237
-121
-96
-96
-160
-226
-349
-417
-583
-413
Income Tax Expense
0
0
0
0
0
-1
0
0
0
0
Net Income
-236
-120
-96
-96
-160
-224
-349
-417
-583
-413
Net Profit Margin
-100371.19%
-274565.91%
-214273.33%
-204736.17%
-7273.30%
-37055.70%
-37456.96%
-173883.33%
-93761.41%
-2804.77%

Immunitybio Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-138
-95
-233
-134
-134
-85
-59
-129
-92
Operating Cash Flow
-79
-87
-115
-106
-100
-98
-85
-85
-79
Investing Cash Flow
-8
-15
2
-35
-51
65
9
4
-16
Financing Cash Flow
43
237
200
10
148
15
106
0
172
Change in Cash
-44
134
87
-132
-2
-18
31
-82
76

Immunitybio Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-120
-96
-96
-160
-224
-349
-417
-583
-413
Operating Cash Flow
-38
-48
-63
-152
-171
-274
-337
-366
-391
Investing Cash Flow
-113
99
57
18
-19
-84
27
-30
-12
Financing Cash Flow
-15
-34
0
114
150
505
233
558
281
Change in Cash
-167
15
-7
-19
-40
146
-76
160
-121

Global Institutional Holdings in Immunitybio Inc.

Funds
Holdings
Vanguard Group Inc
2.15%
BlackRock Inc
1.41%
State Street Corp
0.8%
Geode Capital Management, LLC
0.45%
Woodline Partners LP
0.36%

Insights on Immunitybio Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -129.64M → -92.55M (in $), with an average increase of 40.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 40.0K → 26.42M (in $), with an average increase of 58.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IBRX stock has moved up by 8.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 170.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 86.7%

About Immunitybio Inc.

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer (‘nk’) and t cells, tumoricidal macrophages, and memory t cells.
OrganisationImmunitybio Inc.
Headquarters3530 John Hopkins Court, San Diego, CA, United States, 92121
IndustryHealthcare
CEOMr. Richard Gerald Adcock
E-voting on sharesClick here to vote

Key Management of Immunitybio Inc.

Name

Title

Dr. Leonard S. Sender M.D.

Chief Medical Officer of Liquid Tumors & Cell Therapy

Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.Sc.

Executive Chairman of the Board and Global Chief Scientific & Medical Officer

Mr. Richard Gerald Adcock

President, CEO & Director

Ms. Regan J. Lauer

Chief Accounting Officer

Dr. Enrique Diloné Ph.D., RAC

Chief Technology Officer

Mr. Jason R. Liljestrom J.D.

General Counsel & Corporate Secretary

Ms. Sarah Singleton

Chief Communications Officer & Head of Patient Advocacy

Dr. Sandeep K. Reddy M.D.

Chief Medical Officer

Mr. David C. Sachs

Chief Financial Officer

Dr. Barry J. Simon M.D.

Chief Corporate Affairs Officer & Director

FAQs

What is Immunitybio Inc. share price today?

Immunitybio Inc. share price today is $2.76 as on at the close of the market. Immunitybio Inc. share today touched a day high of $2.94 and a low of $2.74.

What is the 52 week high and 52 week low for Immunitybio Inc. share?

Immunitybio Inc. share touched a 52 week high of $7.48 on and a 52 week low of $1.83 on . Immunitybio Inc. stock price today i.e. is closed at $2.76,which is 63.10% down from its 52 week high and 50.82% up from its 52 week low.

What is Immunitybio Inc.'s market capitalisation today?

Immunitybio Inc. market capitalisation is $0.00T as on .

How to invest in Immunitybio Inc. Stock (IBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunitybio Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunitybio Inc. Shares that will get you 0.5435 shares as per Immunitybio Inc. share price of $2.76 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunitybio Inc. Stock (IBRX) from India?

Indian investors can start investing in Immunitybio Inc. (IBRX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Immunitybio Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunitybio Inc. share’s latest price of $2.76 as on September 18, 2025 at 1:29 am IST, you will get 3.6232 shares of Immunitybio Inc.. Learn more about fractional shares .